BI-Lupin Deal To Up The Heat In Indian DPP-4 Market

Innovator firms continue to tap into the marketing muscle of domestic companies as they vie for a bigger share of India's highly competitive dipeptidyl peptidase-4 (DPP-4) inhibitor market.

More from Alimentary/Metabolic

More from Therapy Areas